A novel dimeric dipeptide mimetic of the BDNF selectively activates the MAPK-Erk signaling pathway


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

On the basis of the structure of beta-turn of loop 2 of brain-derived neurotrophic factor (BDNF), its new dimeric dipeptide mimetic bis-(N-hexanoyl-L-seryl-L-lysine) hexamethylenediamide (GTS-201) was created. It activated TrkB and Erk, did not activate Akt, and exhibited neuroprotective activity in vitro at concentrations of 10–5–10–8 M. Unlike the mimetics that activate Erk and Akt, GTS-201 did not exhibit antidepressant properties. For the manifestation of the antidepressant activity of BDNF mimetics, the activation of its both major signaling pathways is required.

Авторлар туралы

T. Gudasheva

Zakusov Research Institute of Pharmacology

Хат алмасуға жауапты Автор.
Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

A. Tarasiuk

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

N. Sazonova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

P. Povarnina

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

T. Antipova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

S. Seredenin

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Ресей, ul. Baltiiskaya 8, Moscow, 125315

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Ltd., 2017